Vonafexor Lysine

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameVonafexor Lysine
Drug Alias NameEYP-001 L-lysinePLX-007 L-lysineVonafexor L-lysineEYP-651EYP651
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR agonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsDiabetic NephropathiesKidney DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesENYO Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesENYO Pharma Sa
Inactive CompaniesN/A
Active IndicationsDiabetic NephropathiesKidney DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A